Truist analyst Mark Hughes lowered the firm's price target on Markel to $1,950 from $2,100 and keeps a Hold rating on the shares. The firm cites the company's below-consensus Q1 results as well as a lower assumed contribution from its non-insurance operations, also reducing its price target on multiple compression across the P&C carrier group, the analyst tells investors in a research note.
